Therefore, the current study was initiated with the primary aim of examining the potential impact of genetic variants within the CYP1A2 gene, specifically rs762551 and rs2069514, on an individual’s vulnerability to bladder cancer. The gene discussed is CYP1A2; the disease is urinary bladder carcinoma.